Lana Medical Co. (9587.SR)

SAR 45.9

(0.11%)

EBITDA Summary of Lana Medical Co.

  • Lana Medical Co.'s latest annual EBITDA in 2023 was 4.56 Million SAR , down -18.91% from previous year.
  • Lana Medical Co.'s latest quarterly EBITDA in 2024 Q2 was 5.68 Million SAR , down 0.0% from previous quarter.
  • Lana Medical Co. reported an annual EBITDA of 6.56 Million SAR in 2022, down -3.49% from previous year.
  • Lana Medical Co. reported an annual EBITDA of 8.08 Million SAR in 2021, up 52.85% from previous year.
  • Lana Medical Co. reported a quarterly EBITDA of N/A for 2023 FY, down -18.91% from previous quarter.
  • Lana Medical Co. reported a quarterly EBITDA of N/A for 2022 FY, down -3.49% from previous quarter.

Annual EBITDA Chart of Lana Medical Co. (2023 - 2019)

Historical Annual EBITDA of Lana Medical Co. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 4.56 Million SAR -18.91%
2022 6.56 Million SAR -3.49%
2021 8.08 Million SAR 52.85%
2020 4.6 Million SAR 0.0%
2019 2.6 Million SAR 0.0%

Peer EBITDA Comparison of Lana Medical Co.

Name EBITDA EBITDA Difference
Mouwasat Medical Services Company 986.81 Million SAR 99.537%
Dallah Healthcare Company 631.92 Million SAR 99.277%
National Medical Care Company 323.02 Million SAR 98.586%
Al Hammadi Company For Development and Investment 438.27 Million SAR 98.958%
Middle East Healthcare Company 551.23 Million SAR 99.171%
Dr. Sulaiman Al Habib Medical Services Group Company 2.54 Billion SAR 99.82%
Canadian General Medical Center Complex Company 19.92 Million SAR 77.075%
Arabian International Healthcare Holding Company 111.1 Million SAR 95.889%
Future Care Trading Co. 15.6 Million SAR 70.737%
Naba Alsaha Medical Services Company 65.27 Million SAR 93.003%
Al-Modawat Specialized Medical Co. 20.76 Million SAR 78.008%